SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-19-001212
Filing Date
2019-02-28
Accepted
2019-02-27 17:52:42
Documents
103
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20181231x10k.htm 10-K 4231158
2 EX-10.26 clvs-20181231ex10266c482.htm EX-10.26 273510
3 EX-10.38 clvs-20181231ex1038b722c.htm EX-10.38 248783
4 EX-10.39 clvs-20181231ex1039c38a5.htm EX-10.39 136257
5 EX-23.1 clvs-20181231ex2319f86eb.htm EX-23.1 5399
6 EX-31.1 clvs-20181231ex31141adf0.htm EX-31.1 19893
7 EX-31.2 clvs-20181231ex312a795fa.htm EX-31.2 20136
8 EX-32.1 clvs-20181231ex3218f30a5.htm EX-32.1 7991
9 EX-32.2 clvs-20181231ex3227c4119.htm EX-32.2 8380
10 GRAPHIC clvs20181231x10k001.jpg GRAPHIC 195059
11 GRAPHIC clvs20181231x10k002.jpg GRAPHIC 74560
  Complete submission text file 0001558370-19-001212.txt   15635121

Data Files

Seq Description Document Type Size
12 EX-101.INS clvs-20181231.xml EX-101.INS 3505218
13 EX-101.SCH clvs-20181231.xsd EX-101.SCH 69195
14 EX-101.CAL clvs-20181231_cal.xml EX-101.CAL 103306
15 EX-101.DEF clvs-20181231_def.xml EX-101.DEF 255638
16 EX-101.LAB clvs-20181231_lab.xml EX-101.LAB 713680
17 EX-101.PRE clvs-20181231_pre.xml EX-101.PRE 531001
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 19639221
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences